NEW PIPERAZINE COMPOUND AND USE THEREOF AS A HCV POLYMERASE INHIBITOR

• 收藏
• 分享

专利权人:

Hiroyuki Abe;Dai Motoda;Junichiro Tsuruha;Satoki Doi;Tsuyoshi Adachi;Makoto Shiozaki;Akira Suma;Masahiro Yokota;Toru Noguchi;Kazuyuki Sugimoto;Kazuhito Ueyama;Masahiro Tanaka;Kiyosei Ilo

发明人:

Hiroyuki Abe,Masahiro Tanaka,Kazuyuki Sugimoto,Akira Suma,Masahiro Yokota,Makoto Shiozaki,Kiyosei Ilo,Kazuhito Ueyama,Dai Motoda,Toru Noguchi,Tsuyoshi Adachi,Junichiro Tsuruha,Satoki Doi

申请号：

US13093620

公开号：

US20120107273A1

申请日:

2011.04.25

申请国别(地区):

US

年份:

2012

代理人:

摘要：

The present invention relates to a compound represented by the following formula [I]wherein each symbol is as defined in the specification, or a pharmaceutically acceptable salt thereof, or a solvate thereof and an anti-HCV agent and an HCV polymerase inhibitor containing this compound. The compound of the present invention shows an anti-HCV activity based on the HCV polymerase inhibitory activity, and useful as an agent for the prophylaxis or treatment of hepatitis C.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/